Zackova D, Semerad L, Faber E, Klamova H, et al. Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF. Leukemia 2024 Mar 12. doi: 10.1038/s41375-024-02215.
PMID: 38472478